OPEN APP
Home / News / India /  Covid vaccination for 12+ in India likely to start from next month
Listen to this article

All Indian children aged 12 or older will become eligible for COVID-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the matter told Reuters.

The world's first DNA-based COVID-19 vaccine, ZyCoV-D won emergency authorisation from Indian regulators last month. From October, the company, better known as Zydus Cadila, will produce 10 million doses a month.

The vaccine is the only one approved for children in India, which has given a total of 825.9 million doses to adults among its population of nearly 1.4 billion.

ZyCoV-D is a three-dose vaccine which will be administered first on day zero, day 28th and then on the 56th day.

It is a needle-free vaccine administered using The Pharma Jet, a needle free applicator - ‘Tropis’, which ensures painless intradermal vaccine delivery.

Last month, the government's Department of Biotechnology (DBT) said that the "plug-and-play" technology on which the plasmid DNA platform is based can be easily adapted to deal with mutations in the virus, such as those already occurring.

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout